II. History: Presenting emergency complaints in ESRD
- Abdominal Pain
- Chest Pain
- Dyspnea
- Electrolyte abnormalities (see management below)
- Fever
- Hypotension or Syncope
- Generalized symptoms related to inadequate or excessive Dialysis
- Shunt related complications
- Shunt thrombosis (or stenosis from intimal hyperplasia)
- See evaluation and management below
- Shunt bleeding
- Steal Syndrome (limb ischemia during Dialysis)
- Shunt thrombosis (or stenosis from intimal hyperplasia)
-
Dialysis related complications (see Hemodialysis)
- Dialysis Disequilibrium Syndrome (rare, but potentially lethal)
- Hemolysis
- May result from nitrates, chloramines or dialysate heated to >46 C
- Air Embolism (rare now in U.S.)
- With older technology, air emboli complicated as many as 1 in 2000 Dialysis runs
- Air emboli could be as large 60-125 ml air
- Electrolyte abnormalities
- See above
- Hypersensitivity Reaction
- Dialysis membrane (Anaphylaxis)
- Phthalate from PVC tubing
- Ethylene oxide (dialyzer sterilization solution)
- Polyacrylonitrile in membrane (reaction exacerbated in patients taking ACE Inhibitors related to kinin metabolism inhibition)
III. History
-
Renal Failure history
- Reason for Chronic Renal Failure (e.g. Diabetes Mellitus, Hypertension)
- When was Dialysis initially started
- Is urine still made
- Baseline Vital Signs
- Dry Weight
- Typical Blood Pressure and Heart Rate
-
Dialysis schedule
- When was last Dialysis and when is next scheduled
- Missed Dialysis sessions
- In Peritoneal Dialysis, which Dialysis solutions and what is the dialysate appearance
- Retained Kidneys (presents additional risks)
- Hypertension
- Nephrolithiasis
- Infection
IV. Exam
- Vital Signs
-
Vascular Access site
- Audible bruit or palpable thrill
- Absence may suggest shunt thrombosis
- Infection
- Assess site for inflammation or discharge (may be subtle)
- Audible bruit or palpable thrill
- Cardiopulmonary findings
- New Heart Murmurs
- Congestive Heart Failure signs
- Pericardial Effusion signs
- Neurologic findings
- Uremia-induced changes
- Lethargy
- Altered Level of Consciousness
- Myoclonus or asterixis
- Subdural Hematoma related changes (increased risk due to Bleeding Diathesis, Hypertension)
- Focal neurologic deficits
- Altered Level of Consciousness
- Thiamine deficiency related changes
- Ataxia, Confusion, and Ophthalmoplegia
- See Wernicke's Encephalopathy
- Uremia-induced changes
- Gastrointestinal findings
- Rectal Exam (for blood)
V. Labs
- Comprehensive metabolic panel
- Review Serum Creatinine, Blood Urea Nitrogen and serum Electrolytes
- Serum Magnesium
- Serum Phosphorus
- Coagulation tests (INR, PTT)
- Complete Blood Count
- Urinalysis (if not anuric)
VI. Differential Diagnosis
VII. Management
- See Hemodialysis (including precautions regarding venipuncture, Blood Pressure)
- See Drug Dosing in Chronic Kidney Disease
- See Dialysis Disequilibrium Syndrome
- See Bloodstream Infections in Hemodialysis
VIII. Management: Cardiovascular collapse
- Hypotension
-
Cardiac Arrest
- See Cardiopulmonary Resuscitation
- Empiric Calcium Chloride (for presumed Hyperkalemia until Serum Potassium level available)
- See Uremic Pericarditis below
-
Uremic Pericarditis (risk of Cardiac Tamponade)
- Presents as Dyspnea, cough and positional Chest Pain (fever may be variably present)
- Cardiac Tamponade will present with cardiovascular collapse, Pulsus Paradoxus, EKG electrical alternans
- Early Cardiac Ultrasound to evaluate for Cardiac Tamponade
- Initiate aggressive fluid Resuscitation
- Pursue emergency Dialysis
- Emergency Pericardiocentesis if cardiovascular collapse
- Sepsis
- Malignant Hypertension (including Hypertensive Encephalopathy)
-
Acute Pulmonary Edema
- Consider strongly if weight at presentation >5 pounds over baseline weight (dry weight) or missed Dialysis
- Consult with Nephrology regarding emergent Dialysis
- See Acute Pulmonary Edema Management
-
ESRD specific CHF Management
- In general, follow Acute Pulmonary Edema Management standard protocol
- Employ Diuretics, ACE Inhibitors, Nitroglycerin< BiPap and oxygen
- Furosemide (Lasix) 60-100 mg IV (higher dose)
- Avoid Furosemide rate of administration >5 mg/min (risk of Ototoxicity)
- Other measures in refractory, severe Fluid Overload in ESRD
- Emergent Dialysis
- Consider early Endotracheal Intubation or CPAP/BIPAP
- Nesiritide
- Typically avoided now in CHF exacerbations overall (due to lack of efficacy)
- However, not renally metabolized and lowers capillary wedge pressure
- Dosing: 2 mcg/kg IV bolus, followed by 0.01 mcg/kg/min IV infusion
- Observe for Hypotension (occurs in >10% of cases)
- In general, follow Acute Pulmonary Edema Management standard protocol
- Active bleeding with Coagulopathy
- Increased bleeding risk due to prolonged Bleeding Time, uremic Platelet Dysfunction, Heparin over-coagulation
- Baseline Hemoglobin is typically poor due to decreased erythropoetin, Hemolysis and Bleeding Diathesis
- Consider transfusion for Hematocrit <18%
- Prolonged Bleeding Time reversal
- Desmopressin (Vasopressin, DDAVP)
- Works within 2 hours with a duration of 4-8 hours; may repeat in 8-12 hours
- IV or SQ: 0.3 mcg/kg
- Intranasal: 82 mcg/kg
- Cryoprecipitate (FFP)
- Dose: 10 units IV over 10-15 minutes every 12-24 hours
- Corrects Bleeding Time for 4 hours
- Conjugated Estrogen
- Dose: 25 mg daily for 7 days
- Effects last 21 days
- Desmopressin (Vasopressin, DDAVP)
- Prolonged bleeding due to excessive Heparinization
-
Air Embolism (rare)
- Presentation with Chest Pain, Dyspnea, Hypotension (or Cardiac Arrest)
- Exam may demonstrate "millwheel" Heart Murmur
- Incoming access lines should be clamped
- Position patient in trendelenburg and supine or left lateral decubitus position
- Consider hyperbaric oxygen
- Right ventiricular outflow aspiration has been attempted in Cardiac Arrest due to Air Embolism
IX. Management: Shunt Abnormalities
- Shunt thrombosis (or stenosis from intimal hyperplasia)
- Maintaining Vascular Access in Renal Failure costs more than $1 billion/year in U.S. (and increasing)
- Bruit or thrill over access site is absent in shunt obstruction
- Confirm shunt thrombosis with dupplex Doppler Ultrasound
- Discuss with nephrology and vascular surgery (or Intervention Radiology) at an early stage
- Timing of shunt revascularization depends on patient status
- Emergent revascularization or Central Line access (today)
- Emergent Dialysis needed (e.g. Hyperkalemia, Fluid Overload)
- Central Line Placement is typically recommended
- Femoral line preferred in this case to preserve neck and upper extremity vessels for shunts
- Urgent revascularization (within 24 hours)
- Otherwise stable ESRD patient
- Emergent revascularization or Central Line access (today)
- Revascularization techniques
- Shunt Angioplasty
- Directed Thrombolysis at shunt access site
- Angiographic removal of clot
- Tunneled-cuffed catheter revascularization
- Tunneled catheters thrombose commonly (>50% within 1 year)
- Tissue Plasminogen Activator (TPA) 1-2 mg in each lumen
- Hilleman (2011) Pharmacotherapy 31(10): 1031-40 [PubMed]
- Steal Syndrome (limb ischemia during Dialysis)
- Presents with distal extremity pain with a cold, pale, numb, weak ischemic changes and absent or weak distal pulse
- Management
- Coil embolization of collateral Hemodialysis veins (more recent technique) or
- Access ligation and banding
-
Vascular Access
Hemorrhage
- Carefully monitor for bruit or thrill over the access site before and after procedures to stop bleeding
- Apply direct light pressure to puncture site for 10-15 minutes
- Firm enough to stop bleeding, but not so firm as to risk vascular obstruction and thrombosis
- Apply pressure proximal and distal to the bleeding site
- Consider topical agents (in combination with manual pressure)
- Consider over-Anticoagulation (during Dialysis) as a cause for bleeding
- Protamine 0.01 mg per IU of Heparin
- Consider DDAVP
- Consider Tranexamic Acid (TXA)
- Observe in Emergency Department for 1-2 hours after bleeding has stopped before discharge
- See reversal of Bleeding Time above
- Life-threatening bleeding
- Emergent vascular surgery Consultation
- Tourniquet (risk of thrombosis, limb ischemia) or Blood Pressure cuff inflated above systolic Blood Pressure
- Monofilament 3-0 simple purse-string Suture over the bleeding site (risk of fistula injury)
- Maintain manual pressure above and below the bleeding site to clear blood
X. Management: Electrolyte Disturbance
-
Hyperkalemia
- Presents with weakness, Arrhythmias, Hypotension and EKG changes
- See Hyperkalemia Management
- Temporize with Calcium Gluconate 10% IV over 2-5 minutes until Serum Potassium level available
- Contributing factors
- Most likely before Dialysis run (or inadequate dailysis)
- Excessive Potassium intake
- Hemolysis (secondary to Gastrointestinal Bleeding or similar)
- Rhabdomyolysis
- See Hyperkalemia due to Medications
-
Hypermagnesemia
- Presents with profound Muscle Weakness and hyporeflexia
- Arrhythmia and cardiovascular collapse risk if Serum Magnesium >10 mEq/dl
- Temporize with Calcium Chloride or Calcium Gluconate for cardiac stabilization
- Use Calcium dosing as in Hyperkalemia Management protocols
-
Hypercalcemia
- Presents with Vomiting, weakness, and Hypertension (Altered Level of Consciousness in severe cases)
- Consult nephrology for possible Hemodialysis with low Calcium bath
- Fluid challenges (250 ml per bolus) followed by reassessment of fluid status
- Consider synthetic salmon Calcitonin
XI. Management: Hospitalization Criteria
- Emergency Hemodialysis required
- Fluid Overload (with Pulmonary Edema)
- Hyperkalemia (especially Serum Potassium >7 or EKG Changes)
- Cardiopulmonary conditions
- Cardiac Tamponade
- Air Embolism (suspected)
- Chest Pain during Dialysis
- Arrhythmia (Clinically Significant)
- Uncontrolled bleeding at Dialysis access site
- Severe Refractory Hypertension (Hypertensive Urgency or Hypertensive Emergency)
- Diastolic Blood Pressure >130 mmHg despite aggressive management
- Malignant Hypertension (especially Hypertensive Encephalopathy)
- Neurologic conditions
- Altered Level of Consciousness
- Disequilibrium Syndrome (suspected)
- Gastrointestinal conditions
- Gastrointestinal Bleeding (e.g. Peptic Ulcer, Diverticular Bleeding) with hemodynamically significant changes
- Persistent Vomiting with inability to maintain oral hydration
-
Fever with serious findings or risks
- Pneumonia
- Urosepsis
- Shunt-site infection
- Central venous catheter related bloodborne infection
- Ill or toxic appearance
- Dyspnea
- Hypotension
- Symptomatic Electrolyte disturbance (in addition to Hyperkalemia listed above)
- Hypermagnesemia
- Hypercalcemia (with cardiovascular or neurologic dysfunction)
XII. References
- Campana (2014) Crit Dec Emerg Med 28(4): 2-8
- Glauser (2013) Crit Dec Emerg Med 27(10): 2-12
- Guest and Coggins in Swadron (2022) EM:Rap 22(8): 7
- Mallemat, Swaminathan and Egan in Herbert (2014) EM:Rap 14(10): 5